insights_auto
Kwa nini INO imeongezeka kwa 3.68%?
Fahamu zaidichevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ 1.69
arrow_upward
+3.68%(+0.060) Siku 1
US$ 1.69
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 18 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya INO...
Fungua
US$ 1.64
Juu
US$ 1.71
Chini
US$ 1.56
Mtaji wa soko
316.55M
Wastani wa kiasi cha mauzo
19.92M
Kiasi cha mauzo ya hisa
11.58M
Juu kwa wiki 52
US$ 2.72
Chini kwa wiki 52
US$ 0.57
EPS
-US$ 0.80
Beta
1.71
Hisa za wawekezaji
187.31M
Idadi ya wafanyakazi
112
Fungua
US$ 1.64
Juu
US$ 1.71
Chini
US$ 1.56
Mtaji wa soko
316.55M
Wastani wa kiasi cha mauzo
19.92M
Kiasi cha mauzo ya hisa
11.58M
Juu kwa wiki 52
US$ 2.72
Chini kwa wiki 52
US$ 0.57
EPS
-US$ 0.80
Beta
1.71
Hisa za wawekezaji
187.31M
Idadi ya wafanyakazi
112
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Investing.com
·
dakika 11 zilizopita
Inovio at Jefferies Global Healthcare Conference: launch begins
News Corp
·
saa 1 iliyopita
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Investing.com
·
saa 10 zilizopita
Inovio submits European approval application for RRP treatment
Yahoo Finance
·
saa 20 zilizopita
Inovio Pharmaceuticals (INO) Stock Gets Fair Value Boost After VOCERYQ Approval
Wasifu
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Kuhusu Inovio Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)Jacqueline Shea
Wafanyakazi112
Lilianzishwa1999
Makao makuu-
SektaHealth Care
Sekta-
Tovutiinovio.com